NCT07674420进行中（未招募）不适用
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2023年10月17日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 17
- 试验地点
- 1
- 主要终点
- Plantar ulcer recurrence
研究概览
简要总结
The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care in reducing plantar ulceration in high-risk individuals. The investigators aim to understand participant quality of life, the economic impact and cost-effectiveness of the Orpyx SI insole system, and to evaluate participant engagement and compliance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed Type 1 or 2 diabetes
- •Clinically diagnosed neuropathy via Neuropathy Monofilament Test (Appendix A)
- •Qualification as a "high-risk participant," meaning a recent history (<12 months) of a healed diabetic neuropathic ulceration on the weight-bearing surface of one or both feet (this includes the plantar distal toe surface)
- •Complete healing of any previous foot ulcers, as defined by complete re-epithelialization of that ulcer which is confirmed by two medical exams that occur at least two weeks apart (screening visit and baseline study visit)
- •Ability to walk independently (without use of wheelchair) for 30 steps. Use of a walker or cane is acceptable as long as the participant can walk for at least 30 steps.
- •Aged >18 years
- •Ankle-Brachial Index (ABI) > 0.6 or Toe-Brachial Index (TBI) > 0.4 or palpable pulses or evidence of healing in the last 2 months. If ABI < 0.4, the patient's vascular lab studies (ABI, TBI, pulse volume recordings) will be reviewed by the study Principal Investigator and a Co-Investigator vascular surgeon
- •Subject is willing and able to maintain the required offloading (as applicable for the location of the healed ulcer)
- •Subject is willing and able to wear the Orpyx Sensory Insoles during ambulatory activity and at home during waking hours, and for a minimum of 5 hours per day
- •Amputations, if present, are compatible with the use of insoles at physician discretion (e.g. Transmetatarsal Amputation (TMA) are acceptable)
排除标准
- •Active ulcer or presence of other open chronic wound (on foot or leg), regardless of etiology (e.g., vasculitis, neoplasms, or hematological disorders)
- •Psychiatric illness or social situations that would limit compliance with the study
- •Significant cardiopulmonary, severe imbalance, or other systemic disease limiting the participant's ability to walk at least 30 steps or to stand for an amount of time equal to or greater than five (5) minutes (self-reported)
- •Current participation in another clinical investigation of a similar medical device designed to offload or prevent diabetic foot ulcer formation; or participation in such a study within 30 days prior to study enrollment, per physician discretion
- •Current enrollment in any other remote patient pedal monitoring (RPPM) program
- •Osteomyelitis or gangrene of the lower extremity
- •Uncorrected plantar Charcot neuroarthropathy
- •Bunion which would predispose ulcer formation (clinician discretion)
- •Extreme equinus
- •At the start of V1, and prior to randomization, the subject no longer meets the entrance criteria (inclusion and exclusion)
- •Above ankle amputation
- •Amputations not compatible with the insole, per physician discretion
- •Foot deformities or amputations that require surgical intervention as the next step in standard of care, and that the study footwear and device would not adequately address (to be adjudicated by an outside review panel).
- •Brannock-measured foot size > Men's 14 (Women's 12)
- •Physician discretion
研究组 & 干预措施
Orpyx Sensory Insole System Intervention
Experimental
干预措施: Orpyx Sensory Insole System (Device)
结局指标
主要结局
Plantar ulcer recurrence
时间窗: Baseline to End of Study (3 months)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
Study to evaluate effectiveness of cream for participants with diabetic foot ulcers and bedsores.CTRI/2024/10/075076Albert David Limited100
招募中
不适用
Studying the effect of local application of Shodhan Keshari ointment in Diabetic foot ulcer.CTRI/2025/08/093820Government Ayurved College Nanded150
进行中（未招募）
2/3 期
A Study on Aloe Vera Gel for Healing Foot Wounds in People with Diabetes in IndiaCTRI/2025/04/085953122
招募中
不适用
Plantar Pressure and Acceptance of the LEEF-shoe in Individuals With Diabetes-related NeuropathyDiabetic NeuropathyNCT07488104University Medical Center Groningen30
招募中
不适用
FeetSee Thermal Images Collection Protocol in Diabetes PatientsDiabetic Foot UlcerNCT07300163Diabetis JSC100